Risk of SARS-CoV-2 Infection Among Households With Children in France, 2020-2022

被引:5
|
作者
Galmiche, Simon [1 ,2 ,3 ]
Charmet, Tiffany [2 ]
Rakover, Arthur [2 ]
Schaeffer, Laura [2 ]
Cheny, Olivia [4 ]
von Platen, Cassandre [4 ]
Omar, Faiza [5 ]
David, Christophe [5 ]
Mailles, Alexandra [6 ]
Carrat, Fabrice [7 ]
Fontanet, Arnaud [1 ,2 ,8 ]
机构
[1] Inst Pasteur, Emerging Dis Epidemiol Unit, 25 Rue Docteur Roux, F-75015 Paris, France
[2] Univ Paris Cite, Inst Pasteur, Emerging Dis Epidemiol Unit, Paris, France
[3] Sorbonne Univ, Ecole Doctorale Pierre Louis Sante Publ, Paris, France
[4] Univ Paris Cite, Inst Pasteur, Ctr Translat Sci, Paris, France
[5] Inst Ipsos, Dept Publ Affairs Publ Stat, Paris, France
[6] Sante Publ France, St Maurice, France
[7] Sorbonne Univ, Hop St Antoine, AP HP, INSERM,IPLESP, Paris, France
[8] Conservatoire Natl Arts & Metiers, Unite PACRI, Paris, France
关键词
SEROPREVALENCE; VACCINE; ADULTS;
D O I
10.1001/jamanetworkopen.2023.34084
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Importance Understanding the contribution of children to SARS-CoV-2 circulation in households is critical for designing public health policies and mitigation strategies.ObjectiveTo identify temporal changes in the risk of SARS-CoV-2 infection in people living with children.Design, Setting, and ParticipantsThis case-control study included online questionnaire responses from French adults between October 2020 and October 2022. Eligible cases were adults with ongoing SARS-CoV-2 infection with an email address on record with the national health insurance system, which centralized all new diagnoses in France. Eligible controls were adults who had never tested positive for SARS-CoV-2 until February 2021, when eligibility was extended to all adults without ongoing SARS-CoV-2 infection.Exposure Transmission of SARS-CoV-2 from a child (aged under 18 years) within the household in the descriptive analysis, as reported by the participating case. Sharing household with a child (of any age or broken down by school level) in the case-control analysis.Main Outcome and MeasuresOngoing SARS-CoV-2 infection diagnosed by reverse transcription-polymerase chain reaction or supervised rapid antigen test (ie, not self-tests).Results A total of 682 952 cases were included for the descriptive analysis (68.8% female, median [IQR] age, 44 [34-55] years). Among those, 45 108 (6.6%) identified a household child as the source case; this proportion peaked at 10.4% during the Omicron BA.1 wave (December 20, 2021, to April 8, 2022). For the case-control analysis, we matched 175 688 cases (with a 4:1 ratio) for demographic characteristics with 43 922 controls. In multivariable logistic regression analysis, household exposure to children was associated with an increased risk of infection mainly at the end of summer 2021 (receding Delta wave) and during winter 2022 (Omicron BA.1 wave). In subgroup analysis by school level of the child, living with children under the age of 6 was associated with increased odds of infection throughout the study period, peaking at an odds ratio (OR) 1.8 (95% CI, 1.6-2.1) for children looked after by professional in-home caregivers, 1.7 (95% CI, 1.5-1.7) for children in day care facilities, and 1.6 (95% CI, 1.4-1.8) for children in preschool. The ORs associated with household exposure to children aged 6 to 14 years increased during the Delta (August 14, 2021, to December 19, 2021) and Omicron BA.1 waves, reaching 1.6 (95% CI, 1.5-1.7) for primary school children and 1.4 (95% CI, 1.3-1.5) for middle school children. Exposure to older children aged 15 to 17 years was associated with a moderate risk until April 2021, with an OR of 1.2 (95% CI, 1.2-1.3) during curfew in early 2021 (December 4, 2020, to April 8, 2021).Conclusions and Relevance The presence of children, notably very young ones, was associated with an increased risk of SARS-CoV-2 infection in other household members, especially during the Delta and Omicron BA.1 waves. These results should help to guide policies targeting children and immunocompromised members of their household.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Risk of SARS-CoV-2 infection in professional settings, shops, shared transport, and leisure activities in France, 2020-2022
    Galmiche, Simon
    Charmet, Tiffany
    Rakover, Arthur
    Cheny, Olivia
    Omar, Faiza
    David, Christophe
    Mailles, Alexandra
    Carrat, Fabrice
    Fontanet, Arnaud
    BMC PUBLIC HEALTH, 2024, 24 (01)
  • [2] Seroprevalence of Antibodies to SARS-CoV-2 in Rural Households in Eastern Uganda, 2020-2022
    Briggs, Jessica
    Takahashi, Saki
    Nayebare, Patience
    Cuu, Gloria
    Rek, John
    Zedi, Maato
    Kizza, Timothy
    Arinaitwe, Emmanuel
    Nankabirwa, Joaniter I.
    Kamya, Moses
    Jagannathan, Prasanna
    Jacobson, Karen
    Rosenthal, Philip J.
    Dorsey, Grant
    Greenhouse, Bryan
    Ssewanyana, Isaac
    Rodriguez-Barraquer, Isabel
    JAMA NETWORK OPEN, 2023, 6 (02) : E2255978
  • [3] Risk for diagnosis or treatment of mood or anxiety disorders in adults after SARS-CoV-2 infection, 2020-2022
    Wang, Christina X.
    Kohli, Rhea
    Olaker, Veronica R.
    Terebuh, Pauline
    Xu, Rong
    Kaelber, David C.
    Davis, Pamela B.
    MOLECULAR PSYCHIATRY, 2024, 29 (05) : 1350 - 1360
  • [4] Molecular Epidemiology and Diversity of SARS-CoV-2 in Ethiopia, 2020-2022
    Sisay, Abay
    Tshiabuila, Derek
    van Wyk, Stephanie
    Tesfaye, Abraham
    Mboowa, Gerald
    Oyola, Samuel O.
    Tesema, Sofonias Kifle
    Baxter, Cheryl
    Martin, Darren
    Lessells, Richard
    Tegally, Houriiyah
    Moir, Monika
    Giandhari, Jennifer
    Pillay, Sureshnee
    Singh, Lavanya
    Ramphal, Yajna
    Maharaj, Arisha
    Pillay, Yusasha
    Maharaj, Akhil
    Naidoo, Yeshnee
    Ramphal, Upasana
    Chabuka, Lucious
    Wilkinson, Eduan
    de Oliveira, Tulio
    Desta, Adey Feleke
    San, James E.
    GENES, 2023, 14 (03)
  • [5] SARS-CoV-2 Reinfection Risk in Persons with HIV, Chicago, Illinois, USA, 2020-2022
    Teran, Richard A.
    Gagner, Alexandra
    Gretsch, Stephanie
    Lauritsen, Jeff
    Galanto, Daniel
    Walblay, Kelly
    Ruestow, Peter
    Korban, Colin
    Pacilli, Massimo
    Kern, David
    Black, Stephanie R.
    Tabidze, Irina
    EMERGING INFECTIOUS DISEASES, 2023, 29 (11) : 2257 - 2265
  • [6] Changes in SARS-CoV-2 seroprevalence and population immunity in Finland, 2020-2022
    Solastie, Anna
    Nieminen, Tuomo
    Ekstrom, Nina
    Nohynek, Hanna
    Lehtonen, Lasse
    Palmu, Arto A.
    Melin, Merit
    EMERGING MICROBES & INFECTIONS, 2023, 12 (02)
  • [7] An overview of SARS-CoV-2 variants circulating in the 2020-2022 period in Lombardy
    Giardina, Federica
    Ferrari, Guglielmo
    Zavaglio, Federica
    Paolucci, Stefania
    Rovida, Francesca
    Campanini, Giulia
    Pellegrinelli, Laura
    Galli, Cristina
    Pariani, Elena
    Bergami, Federica
    Nava, Alice
    Matarazzo, Elisa
    Renica, Silvia
    Fanti, Diana
    Cento, Valeria
    Alteri, Claudia
    Scaglione, Francesco
    Vismara, Chiara
    Perno, Carlo Federico
    Piralla, Antonio
    Baldanti, Fausto
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2023, 107 (04)
  • [8] Transmission of SARS-CoV-2 among underserved pastoralist communities in Kajiado County, Kenya: 2020-2022
    Macharia, Zipporah
    Ogoti, Brian
    Otieno, Magdaline
    Gitonga, Pauline
    Bosco-Lauth, Angela
    Maritim, Marybeth
    Lemarkoko, Esther
    Keya, Aggrey
    Sankok, Joseph
    Gitao, George
    Onono, Joshua
    Oyugi, Julius
    Bowen, Richard A.
    PLOS ONE, 2024, 19 (08):
  • [9] Asthma and the risk of SARS-CoV-2 infection among children and adolescents
    Giubergia, Veronica
    ARCHIVOS ARGENTINOS DE PEDIATRIA, 2023, 121 (01):
  • [10] Asthma and the Risk of SARS-CoV-2 Infection Among Children and Adolescents
    Rao, Saahithi
    Hurst, Jillian H.
    Zhao, Congwen
    Goldstein, Benjamin A.
    Thomas, Laine
    Lang, Jason E.
    Kelly, Matthew S.
    PEDIATRICS, 2022, 149 (06)